生命科学资讯
生物技术与制药领域的最新动态
Editing strigolactone hormone receptor for robust antiviral silencing in rice
A regulatory network promotes apoplastic alkalinization to prime plant immunity in tissues distal to site of infection
Fungal-derived cellobiose metabolic pathway fuels T cells to bypass intratumoral glucose competition
ARPA-H拨款高达1.44亿美元用于抗衰老医学研究
ARPA-H designates up to $144M for anti-aging medical research
担忧特朗普的最惠国待遇推进将“摧毁生物技术创新”，中型企业组建联盟反击。
Worried Trump's MFN push will ‘destroy biotech innovation,’ midsize companies form coalition to fight back
查尔斯河出售制造与发现业务，兑现战略转型承诺。
Charles River sells manufacturing and discovery businesses to fulfill promised pivot
Appointments and advancements for Feb. 25, 2026
Financings for Feb. 25, 2026
In the clinic for Feb. 25, 2026
Other news to note for Feb. 25, 2026
Regulatory actions for Feb. 25, 2026
Alkermes’ Richard Pops to step down after three-decade run as CEO
Charles River sells its CDMO and European discovery businesses
诺和诺德与朗格初创公司签署21亿美元协议，以增强口服药物递送能力。
Novo Nordisk inks $2.1B pact with Langer startup to boost oral drug delivery prowess
辉瑞退出基因疗法后，锁定Beam基因编辑候选药物全球许可权
After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
口音影响癌症研究；狼人考虑其选择
Accent axes a cancer study; Werewolf considers its options
Alkermes首席执行官理查德·波普斯在任职35年后宣布退休
Alkermes CEO Richard Pops to retire after 35-year tenure
美国多州起诉肯尼迪，挑战儿童疫苗全面改革计划。
States sue Kennedy over US childhood vaccine overhaul